Cost-Effectiveness Of HPV Vaccination

What is the Human Papillomavirus? Commonly known as HPV, it is an infection that spreads through sexual contact. There are over one hundred different types of HPV; several types cause genital warts, while other high risk strands can lead to cancer of the cervix, anus, vagina, and penis. Because HPV is often asymptomatic, many people are unaware of their infection status, and thus, their potential for transmitting the virus to a sexual partner. The significance of the Human Papillomavirus is that fifty percent of Americans who are sexually active will contract it within their lives, and at any given point there are twenty million Americans already infected with it (“By the numbers: HPV Vaccine”).

Human papillomavirus is currently affecting the entire US population without discrimination. To mitigate this, the Advisory Committee on Immunization Practices (ACIP) recommended that adolescent girls be required to vaccinate at age 11 – 12 while boys were optional (Kepka et al., 2016). Today, adolescent boys are required to vaccinate too. The focus of this research is about adolescent boys age 12 – 15 in the United States (US). However, the study is not focused on assessing the population at risk. Instead, the focus will be on the state and territory immunization programs that are responsible for meeting the Healthy People 2020 goals for HPV vaccination in males. The sample size will be extracted from the population.

Unfortunately, there is not a vaccination to protect against every type of cancer. However, the Gardasil vaccine guards against certain strands of HPV that cause 70% of cervical cancers in women. When caught early, the Human papillomavirus is treatable, but after the virus has developed into cancer, there is no cure. Therefore, the person affected begins a painful, uncertain journey to try to save her life. The Encyclopedia of Women’s Health states, “Human papillomavirus (HPV) infection may be the most common viral sexually transmitted disease (STD) in this country. As many as 30 million Americans are infected with HPV, and each year, an additional 1 million people become infected.” (“Human Papillomavirus”). When this many people are affected by a disease that can become cancer, it would be doltish not to use available resources to prevent it. “Nationally and internationally, the HPV vaccine will significantly

The HPV virus has gone unseen by many until the recent controversy over the vaccine. However, this virus is thought to be one of the world’s most wide spread STD’s. “According to the Centers for Disease Control and Prevention (CDC), about 6.2 million women and men are newly infected every year” with HPV. HPV has over 100 strains, with more than thirty that are sexually transmitted. Some of these strains are known to cause cervix, vulva, vagina, anus, or penis cancers and others can cause genital warts. “Studies have found the vaccine to be almost 100% effective in preventing diseases caused by the four HPV types covered by the vaccine—including precancers of the cervix, vulva and vagina, and genital warts” (“HPV Questions and

HPV stands for genital human papillomavirus. It is a sexually transmitted virus and according to the Centers For Disease Control (CDC), “More than half of sexually active men and women (in the United States) are infected with HPV at some time in their lives.” (CDC) The National Cancer Institute says there are more than 200 types of HPVs. (Institute) At least 12 of those HPVs cause certain types of cancer, like vaginal and cervical, and genital warts. If you have an HPV virus it usually goes away on its own, and doesn’t have any symptoms. But if it doesn’t go away experts say it is responsible for many of the 10,000 yearly cases of cervical cancer, causing 4000 deaths each year. (CDC)

The debate over the HPV vaccine largely focuses on mandatory vaccination. This has become politicized because the governments are making the vaccine mandatory for girls who are being admitted into schools. This argument for or against the HPV vaccine will be looked at through ethical and economic issues. The ethical issue will focus on morality of a vaccine for a sexually transmitted infection and the question of having parental rights for mandatory vaccination. An extension to the ethical issue is whether boys should be receiving the vaccine to not just protect them from other diseases caused by HPV, but also to decrease the sexual transmission of HPV to girls. The economic issue is the cost to administer the recommended dosage. In the U.S., some families are not insured, or the insurance coverage does not include this vaccine. As well, some underdeveloped countries cannot afford the vaccine because of high purchasing costs from pharmaceutical companies. Yet, with so many scientific articles stating that the vaccine is safe, there will always be safety concerns and skepticism amongst the public.

The Human Papillomavirus (HPV) is the most common sexually transmitted infection (STI). There are over 100 types of HPV, but only 40 types affect the genital area and can cause genital warts and cervical cancer in women (“Human Papillomavirus (HPV) Vaccine”). In 2011 in the United States, 12,109 women were diagnosed with cervical cancer. Of those, 4,092 women died (“Cervical Cancer Statistics”). HPV is not only contracted from sexual intercourse, but also from skin to skin contact, including oral sex. The STI affects males and females involved in both homosexual and heterosexual sexual activities. Over 70 percent of sexually active individuals contract and carry HPV before the age of 80. In order to combat HPV two different brands of HPV vaccination – Gardasil and Cervarix – were created. Both include a vaccination plan of three shots over the course of six months. Gardasil was created by Merck & Co., and was licensed by the FDA in June 2006. The vaccine protects against HPV types 16 and 18, which lead to cervical cancer, as well as types 6 and 11, which cause 90% of genital warts. The FDA later approved Cervarix, created by GlaxoSmithKline, in 2009, which only protects against HPV types 16 and 18 (“Human Papillomavirus (HPV) Vaccine”). Originally, Gardasil was only approved for females, but three years after the release, the vaccine was approved

Schmidt and Parsons investigated the trends of HPV vaccination, interests, and reasons for non-vaccination in young adult women. Results of testing showed that women who had received one or more doses of the vaccine were more likely to be between the ages of 18-21, to be non-hispanic white, to have private health insurance and a usual source of care that has not been delayed, and to have more than a high-school education. Among women 18-26 years of age, the HPV vaccine uptake increased from 11.6% in 2008 to 34.1% in 2012. In 2008 and

According to NPR (2011), the Gardasil will cause $400 on each person. The Mandatory cervical vaccine program will pay money for a portion of the public; it will increase the health care burden. The other portion of the public may need to pay the cervical vaccine by themselves, since many insurance companies may not even have coverage for this vaccine. In addition, this vaccine only covers few HPV strains and the side effect of the vaccine varied in different people. Many doctors did not recommend this vaccine. Instead, they consider Pap smears are more effective and less expensive, which is useful for early cervical pre-cancerous detection (Shapiro,

According to the Centers for Disease Control and Prevention (CDC), Human papillomavirus (HPV) infects roughly 20 million individuals in the United States with 6.1 million new cases each year. There is no cure for HPV, only treatment for associated health problems. There are more than 30 strains of HPV that affect more than half of sexually active individuals in their lifetime. Public health risks involve several types of HPV leading to precancerous lesions and causing 70% of cervical cancer. Cervical cancer, the second most common cancer, affects many women globally. In the United States, nearly 10,000 women are diagnosed with cervical cancer annually and 3,700 of those women die. It has been reported by American Cancer Society that with early

Cervical cancer is the leading cause of cancerous death, in women, since 1950. Approximately 200,000 cervical cancer patients die each year in developing countries. Strains like HPV 16 and 18 cause about 70% of cervical cancer in women– one of the top causes of death in the world (WebMD, 2010, p.1). In the Unites States, about 10,000 women acquire the disease and 3,700 die annually Human Papilloma Virus (HPV) is directly associated as a cause of cervical cancer. This virus affects the skin and genital area and, in some cases, it can also infect the throat and mouth. Since the HPV is passed from one person to another through skin-to-skin or sexual contact, sexually active people are more prone to this virus. Merck

The HPV vaccine is cancer prevention. Over thousands of cases of HPV cancers are detected every year in men and women. The HPV vaccination is important because it can prevent these cancers. The United States Food and Drug Administration approved this vaccine and it is one hundred percent safe. This vaccine is preventive care for the second leading cancer in women. It has been proven to be one hundred percent effective in prevention of cervical cancer, but the vaccine must be given to children between the age of 11 -17 before they become sexually active. After the age seventeen with young women most become sexually active and receive their first pap smear from their gynecologist, receiving the vaccine at this point is not as effective in prevention of cancers. Another benefit of receiving the vaccine during adolescent, is it supports people who may not have the medical knowledge or access to regular medical services.

In young women aged sixteen to thirty years old, does vaccinating for Human Papillomavirus (HPV) compared to not vaccinating lead to a decrease in the expense of treating the complications from HPV?

The Human papillomavirus (HPV) is the virus responsible for cervical cancer. It is one the most common viral sexually transmitted infections. A vaccine was approved in 2006 that is effective in preventing the types of HPV responsible for 70% of cervical cancers and 90% of genital warts. Proposals for routine and mandatory HPV vaccination of girls have become sources of controversy for parents of school-aged youth, legislators, members of the medical community, and the public at large (Cooper et al. 2010).

This article was published online October,2016, which is just one month back. This article is providing the readers with the latest information about Human Papillomavirus Vaccination and the article are most reliable. Besides, over 200 million of HPV had been administered and recommended among people worldwider.